CEPRALOCK

국가: 오스트레일리아

언어: 영어

출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)

유효 성분:

BISMUTH SUBNITRATE

제공처:

INTERVET AUSTRALIA PTY LIMITED

약제 형태:

MISC. INTRA MAMMARY

구성:

BISMUTH SUBNITRATE MINERAL-BISMUTH Active 650.0 mg/g

패키지 단위:

144 x 4 g syringes; 24 x 4 g syringes; 4 g syringe (illegal to sell separately)

수업:

VM - Veterinary Medicine

치료 영역:

MISCELLANEOUS VETERINARY

제품 요약:

Poison schedule: 0; Withholding period: MILK: DO NOT USE in lactating cows or wi thin 4 days of calving. After calving, c olostrum or milk from treated dry cows M UST NOT BE USED for human consumption or processing for 96 hours (8 milkings). MEAT: Zero (0) days. Zero (0) days. Bef ore using this product, confirm the cur rent ESI from Intervet Australia Pty Lim ited on 1800 033 461 or the APVMA websit e (www.apvma.gov.au/residues).; Host/pest details: DAIRY CATTLE - EARLY POST CALVING: [MASTITIS]; DAIRY CATTLE - NON-LACTATING (DRY) PERIO: [MASTITIS]

승인 상태:

Registered

승인 날짜:

2023-07-01

환자 정보 전단

Product Name:
APVMA Approval No:
CEPRALOCK
89964/136583
Label Name:
CEPRALOCK
Signal Headings:
FOR ANIMAL TREATMENT ONLY
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
Constituent
Statements:
650 mg/g BISMUTH SUBNITRATE
(2.6 g Bismuth subnitrate per 4 g syringe)
Claims:
Internal teat sealant for dry cows and heifers.
For the prevention of clinical and subclinical mastitis in dairy cows
during the non-lactating
(dry) period and early post-calving.
Net Contents:
24 x 4 g syringes
144 x 4 g syringes
Illegal to sell syringes separately, unless supplied by veterinarian.
Directions for Use:
Restraints:
DO NOT USE in lactating cows.
Contraindications:
Precautions:
Side Effects:
Dosage and
Administration:
Dosage and administration document is attached.
This section contains file attachment. RLP APPROVED
General Directions:
Milking machine advice: To reduce the potential for CEPRALOCK
accumulation in milking
machines and reduce the risk of particles entering milk in the vat,
thoroughly hand-strip
CEPRALOCK out of each quarter, 10 to 12 strips per quarter, at the
first milking of fresh
cows. Where possible, avoid removal of CEPRALOCK by the milking
machine. Keep
milk from fresh cows out of the vat for a minimum of 8 milkings (10
milkings in induced
cows) or in line with industry standards designed to minimise
colostrums entering milk for
processing.
If possible, use designated clusters and test buckets during this time
to minimise adherence
to rubberware and milk lines. Clean milking equipment carefully to
prevent particles
entering the vat. Change filter socks regularly, particularly if
residual teat sealant is visible
on the filter.
CEPRALOCK is designed to sit in the teat canal during the dry period.
This means that the
administration process should focus on ensuring that the product does
not travel up in the
higher udder tissue. This is in contrast to the administration of
antibiotic dry cow therapy
which is required to be infused into the udder tissue to ensure
efficacy and duration of
treatment. Care should be taken